Monday 30 November 2020

EXPLOSION UP CONTINUES - MODERNA in charge!


Amazingly powerful upsurge in COVID VACCINE STOCKS. These are the days we dreamed of when we got interested in these stocks. 

21 were up - some a lot and six down. The overall average return was an amazing 7.5% were one of the best days yet. 

CureVac had the best day of all with a gain 22%. Moderna had another explosive day on even better news about its vaccine. It has quickly got over the $60B level in market value. It was in the low 20's just a few weeks ago.

Arcturus gained over 20% as well.

VBI, Altimmune, Biontech and Novavax had double digit gains as well.















 

Sunday 29 November 2020

Not much action in the BOTTOM TEN - All the action is up Top


 

Bottom Ten have a very flat week, unlike the Top Ten. 


EBS slips another slot to just 8th worst overall. Ibio flips with Virology.

Saturday 28 November 2020

Thanksgiving week is amazing blow out week for the TOP TEN - NOVAVAX soars!



Up Up and Away. Novavax has a total blow out week. It had the best week of any COVID VACCINE STOCK ever.

It went from a measly return of 441% to a return of 686%. 

All other stocks in the TOP TEN do exceptionally well also. Arcturus and Moderna moved up over 100% in total return. 

The only change in ranking is Sorrento slipping ahead of OncoSec into 4th. 



 

Friday 27 November 2020

EXPLOSIVE THANKSGIVING RALLY - NANTKWEST, ARCTURUS, NOVAVAX and MODERNA LEAD THE WAY!!


The Wednesday before Thanksgiving (November 25, 2020) will do down as the greatest buying opportunity for COVID VACCINE STOCKS.


In a half-day of trading, these stocks exploded up by just under 9%. Every last one except NanoViricides registered a gain.

The number one stock on this blow-out day was NantKwest which gained over 28%. Arcuturus was up over 25%.  Our number one stock, Novavax had its best day in many months with an enormous 22.5% gain. Moderna had a monster day, climbing over the $50B market value level, adding another 16%. 

Sorrento and Inovio both had enormous 18% gains. 

WOW!!



 

Wednesday 25 November 2020

Huge day for Heat Biologics and Moderna



Huge day for Moderna as it gets the OK from EU. It's been a long time since Moderna had a double digit gain -- going up by almost 11%. Heat Biologics performed even better: escalating almost 16%. 

Both VBI and Altimmune were up 9% and Novavax was up just under 8%.

Overall, the stocks had a very strong day - up 2.5% on average.

There were 17 stocks that went up and 10 down.



 

Tuesday 24 November 2020

COVID VACCINE STOCKS crumble - fall almost 3%


Carnage for COVID VACCINE STOCKS. On the day the DOW crosses 30,000 for the first time, these stocks crumble.

The overall average was a loss of 2.8%.  Only three stocks managed to eek out a small gain.

Vaxart reversed from yesterday, leading the way down with a 12% loss.  VBI fell 8.5%, Generex fell 8.1%, Sorrento down 6.2% and Heat Biologics down an even 5%.



 

Monday 23 November 2020

Top Stocks do well, the smaller ones lag. Vaxart is #1 today.


The top vaccine stocks do well today, while most of the smaller ones have a poor day. Only nine were up with 18 down. 

The overall average was a gain of 0.25%.

Vaxart lead the way up with a strong gain of 11.17%. 

Novavax has a strong day up 8.58%. CureVac was up just under 7%. OncoSec was also up over 5%.

iBio had the worst day overall with a loss of over 9%. Generex, NanTKwest and Dynavax had high single digit losses.

 

Sunday 22 November 2020

Flat week for BOTTOM TEN - ATARA moves up



IMV falls into BOTTOM TEN after its return since March falls from 63% to 57%. Atara Bio has climbed to 14th overall with another 40% gain. It has moved from returning 11% two weeks ago to 89%.

CureVac was the top gainer, moving its return up 8%.

 

Saturday 21 November 2020

Moderna and Sorrento making a move towards the top. Translate Bio back in TOP TEN.



Dramatic twists and turns in the top ten. This is becoming a scary stock picker environment. There were three major winners and the rest lost ground - some serious ground. 

In the week of Moderna's Phase III announcement, it went from a return of 245% to 276%, remaining in third place overall. The biggest gainer was Sorrento which went from a 197% return to 248%. This is one of the most volatile of all the COVID VACCINE STOCKS.

Translate Bio went from a return of 111% up to 142% to return to the TOP TEN for the first time since June 28. It's one of the few of these stocks that have moved from the bottom ten to the top ten.

The top two, Novavx and Arcturus, along with OncoSec (4th) had the worst weeks, with their respective returns moved down over 50%.

 

Friday 20 November 2020

An overall positive day - 1.1% gain for the day. BionTech and Vaxart lead the way.


Another modestly higher day for COVID VACCINE STOCKS as they put together a 1.1% overall gain on average. 

14 stocks gained ground and 13 fell.

BionTech continued its volatility since the announcement last week, today volatility on the upside, gaining just under 10%.  Vaxart was next with over an 8% gain.

Both CureVac and Moderna had strong days gaining almost 6%. Moderna is nearing its highest ever market value - over $38 B.

On the downside, Generex fell 6% to lead the way down. Inovio fell 4% to end to finish the week with a loss.



 

Thursday 19 November 2020

Sorrento goes up almost 12% on relatively positive day


A relatively up day with an overall average gain of 1.3%.  17 stocks were up and nine down with one flat.

Sorrento lead the way up with a gain of almost 12%. Generex, Atara and Arcturus had high single digit gains.

Adaptive Biotech fell over 6% to lead the way down.

 

Wednesday 18 November 2020

Flat Day - Generex up 16%



Flat day for COVID VACCINE STOCKS overall. There were 17 that fell and 10 that gained ground.

The top performer was Generex, which leapfrogged up 16%. Arcturus also had a strong day, up over 6%. Adaptive was up almost 6%. 

Inovio lead the way down, falling 5.6%. Emergent was also a big loser, falling 5.4%. Dynavax also fell around 5%.




 

Tuesday 17 November 2020

Stocks fall 1% on average. iBio gets hammered, falling almost 17%. VBI up almost 8%.



COVID VACCINE STOCKS fall 1% on average after a few tumultuous days. iBio got hammered, falling 16.59% to lead the way down. CureVac also had a double digit loss, falling almost 11%. Inovio fell just under 9%. BionTech continued its recent downward trajectory by falling 5%. 

On the upside, VBI gained almost 8%.

 

Monday 16 November 2020

Moderna's big day - iBio, CureVac and Inovio also break out.


On the day of Moderna's big announcement, COVID VACCINE STOCKS advance an average of 1.6% with 13 up and 14 down.

There was significant volatility again with clear winners and losers. iBio was the biggest gainer, up over 15%, Inovio up 14.5% and CureVac p 14%. Moderna ended up 9.6% to reach its highest level yet -- a market cap of almost $39 B.

The biggest loser was last week's biggest winner: BionTech which fell almost 14%. Altimmune and OncoSec were down 7% and another of the big boys, Novavax fell 6%.

 

Sunday 15 November 2020

Atara and CureVac explode up


Atara and CureVac had great weeks and moved up the charts. Otherwise few changes on the BOTTOM TEN.

 

Saturday 14 November 2020

Radical week for COVID VACCINE STOCKS - Big Boys soar


 

A very tumultuous week. The winners really won and the losers really lost. Novavax has continued a two week surge seeing its return go up 42% this week after going up 58% the previous week. It has return of over 500% since March 1.


But the biggest week went to the biggest COVID VACCINE stock: Moderna. Its return went from 179% up to 245%. It has rocketed from 7th to 3rd overall.


OncoSec also had a great week, moving to second overall for the first time. Its return went up 42% from 265% to 307%.


BionTech had a great week as well, moving from 8th to 6th.


Arcturus got hammered this week, falling from second overall to fourth, with total return falling 114%. Altimmune also stumbled badly, falling from fifth to eighth, loosing fully 62% of total return this week. 

Friday 13 November 2020

VBI leads the way up today with a 10% gain.



Another relatively positive day with stocks moving up 1.6% on average. 16 of the stocks went up with 11 down.

VBI was the big winner, up just under 10%. CureVac, Tonix, Novavax and Sorrento gained in the high single digits. Altimmune and Vaxart were the losers today with losses just under 5%.

 

Thursday 12 November 2020

Vaxart and Atara up over 15% - IMV down 13%.


Severe volatility continues for COVID VACCINE STOCKS. Thirteen stocks were up and 14 down. The overall average was a gain of just 1%, but that masks some radical moves both up and down.

Vaxart and Atara exploded up over 15% to lead the way. Generex, Novavax, Altimmune, Moderna and Inovio all had high single digit returns.

On the other hand, IMV lost 13.4% to lead the way down. Dynavax, BionTech, Adaptive, Sorrento and PDS all had high single digit losses.

 

Wednesday 11 November 2020

Amazing bounce back day again - Arcturus up 24%


Amazing bounce back - COVID VACCINE STOCKS rock forward lead by Arcturus with an amazing 24% leap.

Fully five stocks had double digit gains: Vaxart, VBIV, Sorrento, Adaptive and OncoSec. Several more had high single digit returns: Moderna, Novavax, Vir, Dynavax, Altimmune and PDS Bio.  Moderna has reached its highest market value ever.

The average return was 4.7% which marks a superior day. Fully 21 moved forward with five slipping and one flat.



 

Tuesday 10 November 2020

Huge Bounce Back Day - Inovio explodes up!


Amazingly strong bounce back day for COVID VACCINE STOCKS -- an overall average gain of 5.5%. This is one of the best days yet. 

Inovio exploded up 35% to lead the way. Altimmune got more than half of its dreadful collapse yesterday back, climbing 19%. 

Arcturus also bounced back with an almost 14% gain.  CureVac had a 12% gain, Vaxart up 11% and NantKwest up 10%.

Atara, Translate Bio, BionTech, Dynavax, iBio, IMV, OncoSec and GeoVax had high single digit gains.

Major mRna stocks, Novavax was down almost 13% and Moderna fell 2%.

 

Monday 9 November 2020

BionTech up 14% - Terrible Day otherwise.


WHAT A DAY! WHAT A DEVASTATING DAY!! 

On the day BioNTech announced essentially that it has won the race, it went up 14% - was as high as 30% in the pre-market - and much of the rest of the market met their Waterloo. 

The average stock fell 8%. That is flat out as bad as it gets. 

Arcturus, which was #2 overall on the TOP TEN COVID VACCINE STOCK got murdered - falling 45%!! Altimmune lost 37%. Vaxart fell 32%. Let that sink in.

Vir lost 21%. Inovio, Sorrento, NantKwest, PDS Biotech all suffered double digit losses. Most of the rest also got hit hard as well.

CureVac and Moderna had their best days in months with gains of 8% and 7% respectively.  The rest is all bad news.

 

Sunday 8 November 2020

Flat week for the BOTTOM TEN. Dynavax moves to positive territory.



For all the turbulence out there, it was a very flat week for the BOTTOM TEN COVID VACCINE STOCKS. Dynavax was the top performer, with its return going up 10% from -5% to +5%, so we are left with six stocks who lost value since March 1.

Emergent Biosolutions fell into the bottom ten, replacing IMV. Its return at 67%.

 

Saturday 7 November 2020

Bounce back week for COVID VACCINE STOCKS - OncoSec emerges



Bounce back for COVID VACCINE STOCKS this week. OncoSec almost doubled in value and moved up from sixth to third overall. Novavax had a definite bounce back week with a move from 404% return to 462%. Arcturus is emerging as one of the best, moving up to second overall, going from a return of 290% to 357%. 

Sorrento was second in the top ten recently and now is in sixth.

The total return of all COVID VACCINE STOCKS climbed back over the 100% mark to 104%.

 

Friday 6 November 2020

OncoSec and IMV break out on flat day.



Flat day with an overall average of a gain of 0.6% thanks to OncoSec climbing 25% and IMV up over 10% on positive clinical data on non-Covid related clinical results.

Emergent fell almost 5% to lead the way down. 

14 were up, 13 down with one flat.



 

Thursday 5 November 2020

Flat day except Novavax moves up almost 7%



Flat day except Novavax which broke up almost 7%. The rest moved up by 0.1% on average. 13 stocks were up and 13 down. 


PDS Bio gave back a big chunk of yesterday's gains, falling 6.5%.
 

Wednesday 4 November 2020

Post Election Day Very Positive for COVID VACCINE STOCKS


Major up day for COVID VACCINE STOCKS - rocketing up an overall average of 3.5% for one of the best days ever. 21 stocks had gains and six lost ground.

PDS Bio was up over 18%. Several stocks had high single digit gains: VBI, Atara, Alynylam, Altimmune, Inovio, Translate Bio, EBS and Arcturus. 

Vaxart bucked the positive trend with a 5% loss.

 

Tuesday 3 November 2020

Election Day good for Covid Vaccine Stocks. Vaxart leads.



Very positive day for COVID VACCINE STOCKS with an overall average return today of 2.3%. 22 stocks were up with 4 down. 

Vaxart has the best day, up 8.43%  while Dynavax NanTKwest and Adaptive all had plus 5% returns.

 

Monday 2 November 2020

Flat day to start November


Relatively flat day to start the month of November. Ten gained ground and 16 lost ground. Only iBio moved more than 5% as it fell 5.17% today. The top performer was PDS which gained 4%. The overall average was a return of 0.3%.

 

Sunday 1 November 2020

Bottom Ten COVID VACCINE STOCKS drift lower.



Bottom ten COVID VACCINE STOCKS drift lower on tough week to end the month October.

Atara was the poorest performer, with its return going from a gain of 20% to a gain of just 14%. Dynavax fell into negative territory, from a gain of 6% to a loss of 5%.


 

Painful losses to end the month of October - Novavax hit hard



Scary losses to end the month of October. Novavax is still the number one stock but suffered the biggest downgrade in terms of percentage return of any COVID VACCINE STOCK. It went from a return of 482% to a return of 404%. Sorrento's return dropped from 272% down to 220% and fell from second to fourth.

Three stocks managed to buck the losing trend. Arcturus had a very good week, going from a return of 256% to 290% and climbing to the second best performing COVID VACCINE STOCK after Novavax.  OncoSec and Heat Biologics had improved their return from improve by single digits. Other than that, all these stocks have lost ground.

Inovio fell from 8th to 10th, going from a gain of 156% to a gain of 60%.